Fibromyalgia is not classified as an autoimmune disease, though it shares some features with autoimmune conditions

Fibromyalgia does not involve your immune system attacking your own tissues the way autoimmune diseases do. In rheumatoid arthritis or lupus, for example, your immune system produces antibodies that target specific cells or proteins in your body. Blood tests for fibromyalgia do not show these antibodies or the markers doctors look for in autoimmune disease.

That said, fibromyalgia is not a simple inflammatory condition either. Researchers have found that people with fibromyalgia have abnormal levels of certain chemicals in their nervous system—particularly low serotonin and high substance P, a pain-signaling molecule. The condition appears to involve how your brain and spinal cord process pain signals, not a malfunction of your immune system itself.

This distinction matters because it shapes how the condition is diagnosed and treated. Doctors cannot confirm fibromyalgia with a blood test or imaging study the way they can with many autoimmune diseases. Instead, diagnosis relies on your symptom pattern and a physical examination.

Key Takeaways

  • Fibromyalgia does not produce the antibodies or immune markers that define autoimmune disease, and your immune system is not attacking your own tissues.
  • The condition involves changes in how your nervous system processes pain signals, particularly low serotonin and high substance P levels.
  • There is no blood test or scan that confirms fibromyalgia; diagnosis is based on symptom pattern and clinical examination.
  • Some people have both fibromyalgia and an autoimmune disease at the same time, which requires treatment for both conditions.
  • Fibromyalgia is classified as a central sensitization disorder, meaning your nervous system has become more sensitive to pain signals.

Why fibromyalgia is sometimes confused with autoimmune disease

The confusion is understandable. Fibromyalgia causes widespread pain and fatigue, symptoms that also appear in autoimmune diseases like lupus or Sjögren's syndrome. Some people with fibromyalgia also have a positive antinuclear antibody (ANA) test, which is commonly associated with autoimmune conditions. However, a positive ANA alone does not mean you have an autoimmune disease—it can occur in people without any autoimmune condition, and it does not change how fibromyalgia is treated.

Additionally, fibromyalgia often develops after a physical trauma, infection, or period of severe stress. This pattern led some researchers to initially suspect an immune trigger. While infection or stress may play a role in how fibromyalgia develops, the condition itself does not involve ongoing immune system dysfunction.

What central sensitization means

Central sensitization is the term researchers use to describe what happens in fibromyalgia. Your central nervous system—your brain and spinal cord—becomes amplified in how it responds to pain signals. A stimulus that would cause mild discomfort in most people triggers significant pain in someone with fibromyalgia.

This amplification involves several neurochemical changes. Serotonin, which helps regulate pain perception and mood, is typically lower in people with fibromyalgia. Substance P, which transmits pain signals, is often elevated. Additionally, the brain's pain-processing regions show increased activity in response to stimuli that are not normally painful.

Central sensitization is not the same as inflammation or immune activation. It is a functional change in how your nervous system operates. This is why anti-inflammatory medications that work well for autoimmune diseases often do not help fibromyalgia, while medications that affect neurotransmitters—like serotonin reuptake inhibitors—may provide relief.

Can you have both fibromyalgia and an autoimmune disease

Yes. Some people develop fibromyalgia alongside an autoimmune condition like rheumatoid arthritis, lupus, or Sjögren's syndrome. When this happens, you have two separate conditions that require different approaches to treatment.

If you have both, your doctor will typically treat the autoimmune disease with medications that suppress immune activity—such as disease-modifying antirheumatic drugs (DMARDs) or biologics. For the fibromyalgia component, treatment focuses on managing pain through medications that affect the nervous system, physical therapy, and lifestyle strategies. The presence of an autoimmune disease does not change how fibromyalgia itself is managed.

How fibromyalgia diagnosis differs from autoimmune disease diagnosis

Autoimmune diseases are diagnosed partly through blood tests that detect specific antibodies or inflammatory markers. Your doctor orders tests like rheumatoid factor, anti-CCP antibodies, or complement levels, and abnormal results support the diagnosis.

Fibromyalgia has no diagnostic blood test. Instead, diagnosis is based on your symptom history and a clinical examination. The American College of Rheumatology criteria focus on widespread pain lasting at least three months and the presence of other symptoms like fatigue, sleep problems, and cognitive difficulties. Your doctor may order blood work to rule out other conditions—such as thyroid disease or autoimmune disease—but the blood work itself does not confirm fibromyalgia.

This difference can be frustrating. A normal blood test does not mean fibromyalgia is not real; it simply reflects that the condition does not involve the immune markers doctors can measure in a lab.

What research suggests about fibromyalgia's origins

Scientists do not yet fully understand what causes fibromyalgia to develop, but current evidence points to a combination of genetic, neurological, and environmental factors. People with a family history of fibromyalgia are at higher risk, suggesting a genetic component. Certain infections, physical injuries, or psychological stress can trigger the onset, but the condition itself does not involve ongoing infection or immune system attack.

Brain imaging studies show that people with fibromyalgia have structural and functional differences in pain-processing regions compared to people without the condition. These differences appear to be stable over time and do not change based on immune system activity.

Research into fibromyalgia continues to evolve. Some studies explore whether early immune activation might set the stage for central sensitization, but this is different from saying fibromyalgia is an autoimmune disease. The current scientific consensus is that fibromyalgia is a disorder of pain processing, not immune dysfunction.

Treatment implications of fibromyalgia not being autoimmune

Because fibromyalgia does not involve immune system malfunction, treatments that suppress the immune system—like corticosteroids or immunosuppressants—are not effective and are generally not used. Instead, treatment focuses on managing pain and improving function through medications that affect neurotransmitters, physical activity, sleep improvement, and stress management.

The FDA has approved three medications specifically for fibromyalgia: pregabalin (Lyrica), duloxetine (Cymbalta), and milnacipran (Savella). All three work by affecting how your nervous system processes pain signals rather than by suppressing immune activity. Many doctors also prescribe other medications off-label, such as low-dose naltrexone or tricyclic antidepressants, based on the same principle.

Non-medication approaches—including aerobic exercise, cognitive behavioral therapy, and sleep hygiene—are considered core parts of fibromyalgia management and often provide significant benefit. These approaches would not be primary treatments for autoimmune disease, where controlling immune activity is the main goal.

Frequently Asked Questions

If my fibromyalgia blood work is normal, does that mean I don't have it?

Normal blood work is expected with fibromyalgia. The condition does not produce abnormal antibodies or inflammatory markers that show up in standard tests. Your doctor diagnoses fibromyalgia based on your symptom pattern and clinical examination, not on blood test results. Blood work is useful for ruling out other conditions that can mimic fibromyalgia, such as thyroid disease or autoimmune disease.

Can fibromyalgia turn into an autoimmune disease?

Fibromyalgia does not transform into an autoimmune disease. However, some people develop an autoimmune disease at a different point in their life, separate from fibromyalgia. If this happens, you would have two distinct conditions requiring different treatment approaches. Your doctor can monitor for signs of autoimmune disease through periodic blood work if you have symptoms that suggest it.

Why do some fibromyalgia patients have a positive ANA test?

A positive ANA can occur in people without any autoimmune disease, and it does not indicate that fibromyalgia is autoimmune. A positive ANA alone is not enough to diagnose an autoimmune condition; doctors look for additional antibodies and clinical symptoms. If your ANA is positive but other autoimmune markers are negative and your symptoms fit fibromyalgia, the positive ANA does not change your diagnosis or treatment.

Do fibromyalgia medications work differently than autoimmune disease medications?

Yes. Fibromyalgia medications target neurotransmitter systems to reduce pain signal amplification. Autoimmune disease medications suppress immune activity. This is why medications effective for rheumatoid arthritis often do not help fibromyalgia, and why fibromyalgia medications do not treat autoimmune disease. If you have both conditions, you may need medications from both categories.

Should I be tested for autoimmune disease if I have fibromyalgia?

Your doctor may order autoimmune screening if your symptoms suggest it—for example, if you have joint swelling, rashes, or dry eyes alongside fibromyalgia pain. However, routine screening for autoimmune disease is not standard for fibromyalgia alone. Discuss with your doctor whether testing makes sense based on your specific symptoms.